Philippe Sauvage - 28 Feb 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Chief Financial Officer
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
28 Feb 2025
Net transactions value
$0
Form type
4
Filing time
04 Mar 2025, 18:35:56 UTC
Previous filing
09 Oct 2024
Next filing
18 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +500,000 $0.000000 500,000 28 Feb 2025 Class A Common Stock 500,000 $1.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.